Dld Asset Management, LP Altimmune, Inc. Transaction History
Dld Asset Management, LP
- $413 Million
- Q2 2025
A detailed history of Dld Asset Management, LP transactions in Altimmune, Inc. stock. As of the latest transaction made, Dld Asset Management, LP holds 22,600 shares of ALT stock, worth $89,948. This represents 0.02% of its overall portfolio holdings.
Number of Shares
22,600
Previous 22,600
-0.0%
Holding current value
$89,948
Previous $87,000
-0.0%
% of portfolio
0.02%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ALT
# of Institutions
216Shares Held
36.2MCall Options Held
4.92MPut Options Held
4.18M-
Black Rock Inc. New York, NY5.32MShares$21.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.17MShares$20.6 Million0.0% of portfolio
-
State Street Corp Boston, MA2.75MShares$11 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$10.9 Million0.64% of portfolio
-
Geode Capital Management, LLC Boston, MA1.93MShares$7.7 Million0.0% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $195M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...